On Nov 9, 2021 Strand Therapeutics closed a Grant round and raised $400,000 from National Cancer Institute, featuring lead investors National Cancer Institute. About the […]
Grant – Vasomune
On Nov 8, 2021 Vasomune closed a Grant round and raised $6,400,000 from U.S. Department of Defense, featuring lead investors U.S. Department of Defense. About […]
Post-IPO Equity – XOMA
On Nov 4, 2021 XOMA closed a Post-IPO Equity round and raised $35,000,000 from Novartis, featuring lead investors Novartis. About the company: XOMA is located […]
Post-IPO Equity – XOMA
On Nov 4, 2021 XOMA closed a Post-IPO Equity round and raised $35,000,000 from Novartis, featuring lead investors Novartis. About the company: XOMA is located […]
Series A – Parthenon Therapeutics
On Nov 3, 2021 Parthenon Therapeutics closed a Series A round and raised $65,000,000 from Alexandria Venture Investments, Breakout Ventures, Creacion Ventures, KdT Ventures, Northpond […]
Series B – Antios Therapeutics
On Nov 3, 2021 Antios Therapeutics closed a Series B round and raised $75,000,000 from Adage Capital Management, Aisling Capital, Altium Capital, Amzak Health Investors, […]
Series A – Nitrase Therapeutics
On Nov 2, 2021 Nitrase Therapeutics closed a Series A round and raised $7,000,000 from AbbVie Biotech Ventures, Alexandria Venture Investments, Bristol Myers Squibb, Dementia […]
Series A – Nitrase Therapeutics
On Nov 2, 2021 Nitrase Therapeutics closed a Series A round and raised $7,000,000 from AbbVie Biotech Ventures, Alexandria Venture Investments, Bristol Myers Squibb, Dementia […]
Venture Round – Vensica Medical
On Nov 1, 2021 Vensica Medical closed a Venture – Series Unknown round and raised $16,000,000 from Agriline, Israel Biotech Fund, Laborie Medical Technologies, Lewis […]
Series B – Immunai
On Oct 27, 2021 Immunai closed a Series B round and raised $215,000,000 from 8VC, Alexandria Venture Investments, Icon Ventures, Koch Disruptive Technologies, Piedmont Capital, […]
